Login

Swarup Mohanty, CEO & Director of Mirae Asset Investment Managers India, delivers a podium address. 00:10:00

Share On Facebook Share On Twitter

Kim, Mi Seob · President & CEO, Mirae Asset Global Investments

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Milestones Ahead for Lithium Extraction from Play Deposit
00:10:00
Howard Sanders and the Creation of Auldbrass | Howard Sanders, CEO , Auldbrass Partners.
00:10:00
Seamless Remote Work Transition with M-Files' Cloud-Based Document Management
00:10:00
How AI is Changing Business|Ankit Jain, Founding Partner, Gradient Ventures
00:10:00
Structured Notes Explained: Risk, Cost, and Fee Reduction Strategies | Craig Novorr - President and CIO of Paragon Capital Management, Ltd.
00:10:00
Gem Group Presents Semi-Precious Stones to Guyana's Geology Commission for Market Development
00:10:00
Staying True: The Journey of a Quant Investor | Cliff Asness, Chief Investment Officer , AQR Capital.
00:10:00
Hayes Creek Project: Northern Territory Exploration & Development
00:10:00
Rosario Pingaro, CEO of Convergenze SpA SB, Speaks at the Envent Winter Conference in Milan | Rosario Pingaro, CEO, Convergenze SpA Società Benefit.
00:00:00
Emergence 2024: Presentation by Leslie Chong, Managing Director and CEO, Imugene Ltd - Leslie Chong | CEO & Managing Director, Imugene Ltd
00:10:00
Daugava on Mister Spex’s Expansion: From Germany to Europe’s Top Online Eyewear Brand | Dirk Graber , CEO, Mister Spex SE.
00:10:00
Mastering Inflation, Duration, and Preservation: Insights from John Tobin | John Tobin, Managing Director and Portfolio Manager, Epoch Investment Partners

© 2017 - Neuhu+